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Abstract
Background: Host protein-protein interaction networks are altered by invading virus proteins,
which create new interactions, and modify or destroy others. The resulting network topology
favors excessive amounts of virus production in a stressed host cell network. Short linear peptide
motifs common to both virus and host provide the basis for host network modification.
Methods: We focused our host-pathogen study on the binding and competing interactions of HIV-
1 and human proteins. We showed that peptide motifs conserved across 70% of HIV-1 subtype B
and C samples occurred in similar positions on HIV-1 proteins, and we documented protein
domains that interact with these conserved motifs. We predicted which human proteins may be
targeted by HIV-1 by taking pairs of human proteins that may interact via a motif conserved in HIV-
1 and the corresponding interacting protein domain.
Results: Our predictions were enriched with host proteins known to interact with HIV-1 proteins
ENV, NEF, and TAT (p-value < 4.26E-21). Cellular pathways statistically enriched for our
predictions include the T cell receptor signaling, natural killer cell mediated cytotoxicity, cell cycle,
and apoptosis pathways. Gene Ontology molecular function level 5 categories enriched with both
predicted and confirmed HIV-1 targeted proteins included categories associated with
phosphorylation events and adenyl ribonucleotide binding.
Conclusion: A list of host proteins highly enriched with those targeted by HIV-1 proteins can be
obtained by searching for host protein motifs along virus protein sequences. The resulting set of
host proteins predicted to be targeted by virus proteins will become more accurate with better
annotations of motifs and domains. Nevertheless, our study validates the role of linear binding
motifs shared by virus and host proteins as an important part of the crosstalk between virus and
host.
Background
This study focused on the computational identification of
host proteins targeted by an invading virus, using HIV-1
infection as a case study because extensive study at the
molecular level has yielded nearly fifteen hundred experi-
mentally determined HIV-1, human protein interactions,
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which are catalogued in the HIV-1, Human Protein Inter-
action Database [1,2]. Virus and cellular parasite proteins
alter host interaction networks by competing with host
proteins for binding in the host protein-protein interac-
tion (PPI) network [3-5]. Knowledge of which host pro-
teins interact with virus proteins is important for antiviral
drug discovery and treatment optimization using existing
drugs [6]. Experimental approaches for finding virus pro-
tein binding partners in the human proteome have
proved challenging because nearly thirty thousand
human proteins must be tested [7]. Computational
approaches have helped by reducing the number of host
proteins to verify experimentally.
Previous host-pathogen interaction prediction methods
focused largely on finding PPIs between human and cellu-
lar parasite proteins. One recent method found the prob-
ability that two protein domains interact given the human
PPI network, and used this probability to find the likeli-
hood that pathogen and human proteins interact given
their domain profiles [8]. Another method matched
human and pathogen protein pairs to proteins known to
form complexes, and then filtered these interaction candi-
dates based on expression data from human and patho-
gen [9]. Translating these methods to interactions
between HIV-1 and human proteins has been difficult
because HIV-1 proteins have few domains and their struc-
tures are hard to find by comparative modeling. For
instance, to find structures for the N-terminal and C-ter-
minal domains of HIV-1 VIF, two different protein struc-
tures were required for comparative modeling [10].
In our study, we focus on protein interactions mediated
by short eukaryotic linear motifs (ELMs) [11] on HIV-1
proteins and human protein counter domains (CDs)
known to interact with these ELMs. We aim to obtain host
protein sets enriched with known sets of virus targeted
proteins based on ELM and CD associations. The poten-
tial functional roles of interactions mediated by ELMs and
their CDs in viral infection have been addressed in a
number of recent articles [12-14]. The HIV-1 literature
contains at least ten examples of HIV-1, human PPIs that
are directly associated with motif and domain presence.
The motif/domain basis of such PPIs is not restricted to a
single HIV-1 protein, but is widely distributed across the
HIV-1 proteome, including HIV-1 NEF [7], ENV [15], TAT
[16], REV [16], VIF [17], and VPU [18]. This experimental
evidence is the motivation for systematically investigating
the association of motif/domain pairs with PPIs between
virus and host proteins. Although Tastan et al. [19] esti-
mated a relatively weak link between binding motif/
domain presence and the actual virus-host PPIs, their
work was restricted to predicting direct binding between
host and HIV-1 proteins. In this study, we set out to iden-
tify host proteins involved in direct interactions as well as
those that compete with HIV-1 proteins for binding to
their host targets. Moreover, the algorithm presented by
Tastan et al. is based on supervised learning and training
from known interactions between HIV-1 and human pro-
teins. In their method, each potentially interacting protein
pair is associated with a feature vector composed of
parameters related to Gene Ontology (GO), global gene
expression profiles, the human protein interactome, and
protein domains and motifs. Ours is a hypothesis-based
approach, and does not require a priori knowledge of
virus-host interactions beyond what can be gathered from
viral and host protein sequences. As such, it is directly
applicable to identifying host protein sets enriched with
virus targeted host proteins for a wide scope of infectious
diseases. The extremely low p-values we calculated for the
overlap between our predictions and experimentally veri-
fied HIV-1, host protein interactions indicate the potential
value of our approach for deducing a first draft of the
molecular vocabulary employed in less studied host-path-
ogen protein interactions.
Methods
Virus protein ELM annotation and conservation
We downloaded the 2007 versions of multiple protein
alignments for 9 (ENV, GAG, NEF, POL, REV, VIF, VPR,
TAT and VPU) HIV-1 translated open reading frames from
the HIV-1 Sequence Database http://www.hiv.lanl.gov/
content/sequence/NEWALIGN/align.html and removed
all sequences except those labeled as subtypes B or C. We
focused on subtype B because it is most common in the
industrialized world [20], and chose subtype C because it
is most common globally [21]. We computationally
cleaved the GAG alignment into CA, MA, NC, P1, P2, and
P6 alignments, and cleaved the POL alignment into IN,
PR, and RT alignments using [GenBank: NC_001802] as a
reference. All proteins in the resulting 18 alignments were
annotated with ELMs using the ELM resource, accessed
December 2008 [11], using default settings except select-
ing human for the species field. Any protein lacking an
ELM was removed from the study, leaving at least 70
sequences in each multiple alignment [see Additional file
1]. We considered an ELM to be conserved on an HIV-1
protein if it was present on more than 70% of the pro-
tein's multiple alignment. This cutoff was chosen for its
stability. An increase of 5% additional conversation did
not alter the number of conserved ELMs (data not
shown). A total of 99 ELMs were found on at least one
virus protein sequence. The conservation threshold
removed 43 of these, leaving 56 total.
Human protein ELM and CD annotation
The ELM resource lists CDs or proteins known to interact
with ELMs. For each ELM conserved on a virus protein, we
found the appropriate CDs and mapped them to PROSITE
domains [22]. When the ELM resource listed a set of inter-BMC Medical Genomics 2009, 2:27 http://www.biomedcentral.com/1755-8794/2/27
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acting proteins instead of CDs, we assumed that all pro-
teins had a common unknown CD, and annotated them
with that. We constructed a list of CDs and interacting
proteins for each HIV-1 conserved ELM [see Additional
file 2].
We annotated PROSITE domains and ELMs on the 9446
human protein sequences in the Human Protein Refer-
ence Database (HPRD) PPI network [23], and mapped
these sequences to Entrez GeneIDs. PROSITE domains
were annotated with the PROSITE scan tool (release
20.31) using the default parameters [24]. ELMs were
determined by using the ELM resource, accessed August
2008, selecting the same settings used for the HIV-1
sequences. Any protein lacking a PROSITE domain, or not
binding to a protein with a PROSITE domain (other than
itself), was removed from the study, leaving 5954 pro-
teins.
Prediction of human proteins interacting with HIV-1 
proteins
The prediction of HHP, the set of human proteins that
might interact with HIV-1 proteins, was based on interac-
tions mediated by ELMs and CDs. We built HHP from the
union of two sets of human proteins, H1 and H2. H1 was
the set of human proteins predicted to directly interact
with one or more HIV-1 proteins via a human CD and a
virus ELM. H2 was the set of human proteins whose inter-
actions with proteins in H1 were potentially disrupted by
competition with an HIV-1 protein. Here an H1 protein
has a CD that it might use to interact with an ELM present
on both H2 and HIV-1 proteins. For example, in the com-
petition between an HIV-1 and H2 protein for phosphor-
ylation by an H1 kinase, the H1 protein has a kinase CD
and the competing proteins have ELMs for phosphoryla-
tion sites.
The HHP prediction algorithm was straightforward. For
each virus protein, we looked at all interactions docu-
mented in HPRD that could be explained by an interac-
tion between a virus protein's conserved ELM and a CD
known to interact with that ELM, and added the protein
with the CD to H1 and the protein with the ELM to H2.
Human proteins are involved in multiple interactions, so
H1 and H2 are not mutually exclusive. HHP for each virus
protein was the union of the protein's H1 and H2 sets, and
contains all host proteins that either bind to or compete
with the virus protein. HHP has 2348 proteins involved in
23330 predicted HIV-1, human interactions.
Validation using the HIV-1, Human Interaction Database
The HIV-1, Human Protein Interaction Database
(accessed August 2008) has 3,950 interactions between 19
HIV-1 proteins and 1,439 human proteins. All interac-
tions for ENV's 2 cleavage products, GP41 and GP120,
were assigned to ENV. Interactions for GAG and POL
products were shown separately as well as assigned to
GAG or POL. We restricted the human proteins interact-
ing with HIV-1 proteins to those belonging to the set of
5954 proteins that have PROSITE domains and appear in
the HPRD network with at least one non-self edge. The
HIV-1, human interactions are spread over 68 interaction
types, such as "interacts with", "phosphorlates", and
"upregulates". We considered all interaction types, both
direct and indirect. For each HIV-1 protein, we removed
an interaction type if it described less than six interactions.
This resulted in a set of 1,687 verified interactions
between 15 HIV-1 proteins and 887 human proteins,
which we called HHE, and used to investigate the useful-
ness of HHP. We constructed a subset of HHE, DHHE,
which had interaction types deemed to be direct by Tastan
et al. [19]. DHHE was used to evaluate H1.
The statistics in this research focused on the comparison
of our predicted set HHP and the experimental dataset
HHE  based on the overlap between the two sets, GO
molecular function enrichment, and KEGG pathway
enrichment. P-values for the overlap between HHP and
HHE and their various subsets were calculated using the
hypergeometric test in the R Project for Statistical Com-
puting. P-values for GO and KEGG enrichment for a given
protein set compared to a background set of 5954 pro-
teins were found using Bonferroni corrected p-values
from DAVID [25].
Results
Human ELMs were conserved on HIV-1 proteins
Figure 1 shows a subset of the conserved ELMs annotated
on NEF's multiple alignment. It is clear from the figure
that conserved ELMs occur in roughly the same position
on each aligned protein. Our computations showed that
this was true for all conserved ELMs on all HIV-1 proteins.
Noting that HIV-1 is a virus with high mutation rate, these
results support the assertion that conserved ELMs are
essential for viral replication within the host cell [14].
ELM annotation in eukaryotic proteomes is not yet com-
plete. Multiple computational strategies have been
employed for the discovery of additional ELMs involved
in protein interactions and post-translational modifica-
tions [26,27]. It is possible that HIV-1 proteins have addi-
tional conserved ELMs that have not yet been identified.
Conserved ELMs are shown for each HIV-1 protein in Fig-
ure 2. Overall, 56 of the 133 ELMs in the ELM resource
were conserved on some HIV-1 protein. Some of the con-
served ELMs, like the SH3 ligand sites on NEF, have been
experimentally verified as binding sites for human pro-
teins [28]. We found that conserved ELMs could occur fre-
quently on human proteins. ELM LIG_PDZ_3 was seen on
90% of human proteins. Other ELMs, like LIG_EH1_1,BMC Medical Genomics 2009, 2:27 http://www.biomedcentral.com/1755-8794/2/27
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appeared on only a few human proteins [see Additional
file 2].
HHP and HHE occupy the same KEGG pathways and 
share GO terms
HHE contains 887 host proteins known to interact with
one or more HIV-1 proteins. The dataset is noisy as it
includes results from multiple laboratories and varying
methodologies, some of which might not have been sen-
sitive enough to identify direct binding partners within a
collection (complex, aggregate) of proteins. Nonetheless,
HHE was appropriate for the task of assessing HHP. The
HPRD network of the 5954 proteins in the study is shown
in Figure 3D with yellow HIV-1 proteins connected to pro-
teins in HHP (blue) and HHE (red). Proteins in both sets
are purple, while all other proteins are green. As seen in
the figure, HHP was larger in size than the corresponding
HHE for an HIV-1 protein. Proteins in H2 dominated the
overlap between HHP and HHE, and many of the proteins
in H1 were also found in H2. We investigated the useful-
ness of H1 by comparing it with DHHE, the subset of HHE
with only direct interactions, and found that there were
some virus proteins for which there was significant over-
lap between H1 and DHHE [see Additional file 3]. The
upper half of Figure 4 shows the overlap p-values and
sizes of DHHE and H1 for ENV, NEF, and TAT, which were
the HIV-1 proteins with the largest HHE sets.
We found KEGG pathways enriched with proteins from
each virus protein's HHP set (p-value < 0.01, see Meth-
ods). Shown in the lower half of Figure 4 are bar graphs
demonstrating the intersection of HHP in KEGG (or HHP
found in enriched pathways) and HHE for ENV, NEF, and
TAT. Our model predicted 584, 519, and 410 proteins will
interact with ENV, NEF, and TAT, respectively, and
matched 127 of 409, 54 of 155, and 112 of 509 experi-
mentally verified interactions. The p-values indicated a
statistically significant match between predicted and
experimental sets for ENV, NEF, and TAT when using both
direct predictions (H1), and direct predictions in addition
to competing predictions (HHP). However, the p-values
in Figure 4 showed that the overlap between predicted
and experimental data was weaker for H1 and DHHE than
for HHP and HHE.
The intersection between HHP and HHE for HPRD pro-
teins became more significant as we took the projections
of these sets onto the set of human proteins in KEGG
pathways [see Additional file 4]. The significance
improved further when ENV and NEF HHP were further
restricted to genes in KEGG pathways that were statisti-
cally enriched with HHP (p-value < 0.01). One potential
contributor to such low p-values is that host proteins in
KEGG pathways are among the most studied, and there-
fore their interactions with HIV-1 proteins would have
been investigated earlier than the poorly studied host pro-
teins. Nevertheless, the correspondence between statisti-
cally enriched HHP and HHE KEGG pathways (Table 1, p-
value < 0.01) and the enriched GO molecular function
level 5 categories (Table 2, p-value < 0.01), suggested the
co-localization of HHP and HHE in the host proteome.
The KEGG pathways statistically enriched for ENV, NEF,
and TAT interacting proteins (experimental as well as
computational) included immune system pathways such
as T cell and B cell receptor signaling pathways, apoptosis,
focal adhesion, and toll-like receptor signaling pathways
(Table 1). Gene expression data before and after HIV-1
infection of macrophages also showed apoptosis and
MAPK signaling pathways as statistically enriched [29], as
predicted here. Microarray results did not show cell cycle
and toll-like receptor pathways as highly activated in HIV-
1 activated macrophages, although the toll-like receptor
pathway was highly enriched with known HIV-1 targeted
proteins (Table 1). Also statistically enriched were disease
pathways such as the colorectal cancer, leukemia, and
lung cancer pathways that have been shown to have high
incidence of occurrence in HIV-1 infected individuals
[30]. Other disease pathways predicted by our analysis
ELM conservation on NEF Figure 1
ELM conservation on NEF. ELMs were spatially con-
served on alignments of HIV-1 proteins of subtypes B and C. 
Each box shows the annotations for one conserved ELM 
(present on more than 70% of protein instances) on the mul-
tiple alignment of NEF proteins. An ELM can be spatially con-
served in multiple positions on the alignment, demonstrated 
by multiple sets of thick vertical lines in an ELM's box.BMC Medical Genomics 2009, 2:27 http://www.biomedcentral.com/1755-8794/2/27
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included those previously associated with HIV-1 infec-
tion: H. pylori infection [31], E. coli infection [32], and
type II diabetes [33]. These observations indicated the
promise of our method in predicting activated disease
pathways based on viral sequence. Post-translational
modification appeared to be an important element of
HIV-1 cellular network hijacking. As shown in Table 2,
protein kinase activity and protein kinase binding were
highly statistically enriched both in HHP and HHE, sug-
gesting the importance of altered phosphorylation events
in the reorientation of the host cell PPI network towards
virus survival and replication [29]. The HIV-1 activated
GO categories listed in Table 2 are associated with signal
transduction processes in the KEGG pathways presented
in Table 1.
The positions of predicted and matched HIV-1 targeted
proteins along KEGG pathways allowed us to assess the
extent of matching between computational and experi-
mental prediction based on cell-compartment identity.
Figure 5 shows the match (purple) between predicted
(blue) and experimentally determined (red) host proteins
targeted by HIV-1 TAT along the natural killer cell medi-
ated cytotoxicity pathway. Our predictions were on target
on the cell membrane for HLA-B, HLA-A3, HLA-B45, and
FAS, but we missed Perforin, HLA-C, HLA-E, and HLA-G1.
The figure also shows a good match for DNA transcription
factors targeted by HIV-1. The green boxes in the figure
correspond to host proteins with apparently no direct
interaction with TAT.
The cytokines shown in red at the right hand side of the
KEGG diagram in Figure 5 would not be expected to
appear in our predicted list. They belong to HHE, but their
interactions with virus proteins are probably not direct,
but via transcriptional regulation. The T cell receptor sign-
aling pathway in Figure 6 indicates a high degree of
matching (purple) along the cell membrane and on tran-
scription factors between TAT targeted host proteins (red)
and our corresponding predictions (blue). The abundance
of predicted host proteins in the pathway with no match-
ing experimental result suggests new PPI interaction stud-
ies for HIV-1 as well as further refinement of our
computational method.
Conserved ELMs on HIV-1 proteins Figure 2
Conserved ELMs on HIV-1 proteins. Of 133 ELMs scanned, only 56 were conserved ELMs (present on more than 70% of 
an HIV-1 protein's alignment). Yellow boxes indicate conservation of an ELM above 70% for a virus protein. All HIV-1 proteins 
shown had at least one conserved ELM.
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Figure 7 shows a combined view of HHP and HHE, made
by aggregating HHP and HHE for all virus proteins. When
we looked at HHP in KEGG, we had 1047 host proteins,
and 345 of these had already been shown to be interacting
with at least one HIV-1 protein. The match between com-
putational prediction and experimental data in this case
led to a p-value of 1.97 E-62. One reason for the small p-
value is that a host protein was considered to be interact-
ing with HIV-1 even if the protein interacted with an HIV-
1 protein other than the one that was experimentally ver-
ified. Nevertheless, this virus protein insensitive set is
meaningful, as it provides a first estimate of HIV-1 tar-
geted host proteins.
ELM Modules did not perform better than ELMs
Next we asked if restricting our analysis to ELMs and ELM
pairs with low frequencies of occurrence in the host pro-
teome would yield a better HHP, hypothesizing that fre-
quent ELMs were causing false positives. In an effort to
reduce the frequency of ELM occurrence, we looked for
ELM modules, defined as two different ELMs occurring in
a 20 residue window. We identified ELM modules con-
served on more than 70% of each HIV-1 protein's multi-
ple alignment, as we did for ELMs. We found the fraction
of human proteins with each ELM or ELM module, and
chose two frequency cutoffs, 0.25 and 0.50, to restrict the
ELMs and ELM modules on virus proteins to those that
were infrequent on human sequences. Any ELM or ELM
Network diagrams for HIV1, host protein interactions Figure 3
Network diagrams for HIV1, host protein interac-
tions. (A) The scheme for identifying HHP. Rectangular 
blocks represent ELMs and ellipses represent their CDs. (B) 
An HIV-1 protein (yellow) alters the human PPI network by 
creating a new path between proteins (blue). (C) An HIV-1 
protein breaks a path between two human proteins (blue) by 
competing for binding [3-5]. (D) Interactions between HIV-1 
and human proteins, as predicted by HHP and HHE using 
HPRD. Nodes are proteins and edges represent a protein-
protein interaction. Yellow nodes represent HIV-1 proteins. 
Purple nodes represent the overlap between HHP and HHE. 
Blue and red nodes represent proteins specific to HHP and 
HHE, respectively, while green nodes are not involved in 
infection.
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Comparison of H1 and DHHE and HHP and HHE for KEGG  proteins Figure 4
Comparison of H1 and DHHE and HHP and HHE for 
KEGG proteins. The upper half of the figure compares 
direct predictions (H1) with experimentally verified direct 
interactions (DHHE) for ENV, NEF and TAT. The p-values 
indicated a significant overlap for all protein sets. The bottom 
half of the figure compares HHP and HHE for the three HIV-
1 proteins when HHP was restricted to genes in all KEGG 
pathways (ENVa, NEFa, TATa), and KEGG pathways 
enriched (p-value < 0.01, see Methods) with HHP (ENVe, 
NEFe, TATe). The intersection between HHP and HHE was 
significant for both projections, but slightly more significant 
for enriched pathways for ENV and NEF. P-values were cal-
culated as described in Methods.
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module with a human frequency above the cutoff was not
used to predict interactions. Figure 8 shows the results for
ENV, NEF, ad TAT, comparing the use of all conserved
ELMs to using frequency (fraction) cutoffs for conserved
ELMs and ELM modules. The results indicated that such
restrictions on ELMs helped results for ENV, but not for
NEF and TAT. For NEF and TAT, ELM restrictions yielded
smaller HHP, but the overlap between HHP and HHE was
also reduced.
Discussion
The rapid sequencing of viral genomes with next genera-
tion sequencing technology [34] makes it possible to link
clinical parameters of viral infection to sequence motifs.
Table 1: KEGG Pathway Enrichment
ENV HHP ENV HHE NEF HHP NEF HHE TAT HHP TAT HHE
AML 1.97E-05 2.68E-05 2.07E-05 8.55E-05 2.66E-08 3.08E-04
Adherens junction 2.15E-09 NA 8.21E-11 NA 6.74E-06 NA
Apoptosis 4.58E-04 1.43E-13 5.18E-04 6.54E-04 3.91E-03 3.88E-13
B cell receptor signaling pathway 4.86E-06 8.73E-10 2.88E-04 2.90E-04 1.25E-09 5.57E-06
Cell cycle NA NA NA NA 2.88E-04 1.90E-01
CML 7.21E-05 2.23E-05 1.17E-06 2.46E-05 1.01E-09 7.53E-07
Colorectal cancer 1.07E-05 3.18E-04 4.68E-08 3.31E-03 4.50E-04 1.42E-03
Endometrial cancer 6.03E-04 1.62E-02 1.66E-04 2.10E-03 5.03E-07 3.83E-04
Epithelial cell signaling in H. pylori infection 2.29E-04 3.84E-06 2.07E-06 2.83E-05 NA NA
ErbB signaling 2.27E-10 5.70E-04 1.70E-12 9.22E-04 1.53E-12 1.66E-05
Fc epsilon RI signaling pathway 8.43E-04 6.23E-21 2.14E-05 2.20E-07 9.62E-05 1.52E-04
Focal adhesion 2.82E-06 2.30E-03 2.31E-07 6.90E-02 5.28E-08 3.36E-09
Gap junction 1.90E-04 1.26E-04 NA NA 1.12E-04 7.18E-10
Glioma 1.50E-04 1.24E-05 4.99E-06 6.02E-03 1.56E-07 6.79E-11
Insulin signaling 1.53E-07 8.84E-02 1.73E-04 3.50E-01 2.91E-07 7.35E-02
Jak-STAT signaling 4.08E-08 2.15E-04 4.09E-09 1.28E-01 2.32E-17 4.91E-03
Leukocyte transendothelial migration 1.94E-07 2.21E-08 1.17E-08 6.36E-01 3.28E-05 1.45E-01
Long-term potentiation 6.79E-05 2.20E-02 NA NA 9.04E-03 2.38E-10
MAPK signaling 5.19E-08 6.32E-04 1.58E-09 3.27E-03 1.18E-03 5.15E-01
NK cell mediated cytotoxicity NA NA NA NA 9.50E-06 5.31E-15
Non-small cell lung cancer 4.28E-05 1.25E-04 1.26E-05 1.67E-03 7.55E-06 1.45E-06
Pancreatic cancer 1.26E-04 5.54E-07 1.10E-05 2.50E-06 1.03E-05 8.15E-08
Pathogenic E. coli infection – EHEC 3.77E-03 1.00E+00 2.94E-03 NA 9.74E-03 3.25E-01
Phosphatidylinositol signaling system 1.36E-03 1.72E-04 2.37E-03 NA 2.19E-05 9.74E-06
Prostate cancer 1.90E-04 1.26E-04 6.26E-06 6.56E-05 5.46E-09 1.11E-07
Regulation of actin cytoskeleton 4.30E-03 6.02E-01 1.73E-03 8.79E-01 2.66E-03 7.65E-01
Small cell lung cancer 1.94E-03 3.71E-10 8.42E-05 4.25E-02 1.12E-04 4.09E-14
T cell receptor signaling pathway NA NA NA NA 1.56E-06 1.35E-11
Tight junction 1.24E-03 1.00E+00 5.29E-04 NA NA NA
Toll-like receptor signaling pathway 5.16E-03 2.04E-14 5.37E-05 2.04E-14 NA NA
Type II diabetes mellitus NA NA NA NA 3.47E-03 5.95E-01
VEGF signaling 3.23E-03 4.89E-15 6.79E-03 8.82E-03 1.88E-05 4.07E-12
KEGG Pathways enriched (p-value < 0.01, see Methods) in HHP for HIV-1 ENV, NEF, and TAT. HHE enrichment is also indicated.
Table 2: Gene Ontology Enrichment
ENV NEF TAT
HHP HHE HHP HHE HHP HHE
adenyl ribonucleotide binding 9.9E-10 9.9E-10 4.8E-10 4.8E-10 7.8E-12 7.8E-12
inositol or phosphatidylinositol kinase activity 6.6E-06 6.6E-06 1.6E-06 1.6E-06 7.7E-06 7.7E-06
interleukin receptor activity 3.4E-07 3.4E-07 4.7E-08 4.7E-08 6.0E-08 6.0E-08
lipid kinase activity 1.4E-04 1.4E-04 4.9E-05 4.9E-05 1.3E-05 1.3E-05
MAP kinase activity 1.4E-04 1.4E-04 4.1E-05 4.1E-05 NA NA
MAP kinase kinase kinase activity 2.3E-03 2.3E-03 7.5E-04 7.5E-04 NA NA
phosphoric monoester hydrolase activity 4.9E-07 4.9E-07 1.9E-03 1.9E-03 NA NA
protein kinase activity 7.9E-32 7.9E-32 1.6E-28 1.6E-28 6.6E-33 6.6E-33
protein kinase binding 1.1E-05 1.1E-05 1.7E-04 1.7E-04 2.0E-07 2.0E-07
GO molecular function level 5 categories statistically enriched (p-value < 0.01) by HHP for ENV, NEF, and TAT. HHE enrichment is also indicated.BMC Medical Genomics 2009, 2:27 http://www.biomedcentral.com/1755-8794/2/27
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The task of identifying host proteins targeted by a virus is
worthwhile because such proteins may become drug tar-
gets to fight infection [6]. Experimental studies for deter-
mining virus targeted proteins are expensive and highly
challenging [14]. Such efforts, although large-scale, have
produced incomplete results for even well studied viruses
like HIV-1 [6,35,36]. In this study, we used a systems
approach to identify host protein subsets enriched by
virus targeted proteins. Our method was based on the
identification of host motifs on virus sequences. We used
the a priori knowledge in the ELM resource to identify the
counter domains associated with these motifs and infor-
mation from the human interactome to focus on host pro-
tein interaction pairs with appropriate motif/domain
links. KEGG pathways and the GO molecular functions
were used to provide biological context to our findings.
The sets of host proteins we predicted as targeted by a
given HIV-1 protein in KEGG pathways were highly statis-
tically enriched with host proteins known to interact with
the same HIV-1 protein (Figure 4). For example, the
match between our predictions and the interactions for
HIV-1 NEF in the HIV-1, Human Protein Interaction Data-
base corresponded to a p-value of 4.26 E-21 in KEGG
pathways enriched in our predicted set. After combining
our predictions for all HIV-1 proteins, we had 607 pro-
teins in HHP enriched KEGG pathways, and of these we
matched 241 in the set of 877 experimentally verified pro-
teins with a p-value of 3.11 E-58 (Figure 7). Our predic-
tions were not nearly an exact match for experimental
data, but our list was highly enriched with HIV-1 targeted
host proteins. Given that HHP in KEGG pathways is about
half as large as all HHP, and has a stronger overlap with
HIV-1 TAT natural killer cell mediated cytotoxicity Figure 5
HIV-1 TAT natural killer cell mediated cytotoxicity. The KEGG natural killer cell mediated cytotoxicity pathway is 
colored for TAT HHP (blue) and HHE (red), and their overlap (purple). Green boxes have proteins not involved in infection, 
while white boxes do not have human proteins.BMC Medical Genomics 2009, 2:27 http://www.biomedcentral.com/1755-8794/2/27
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HHE, experimentalists should begin verification with this
set.
In addition to the binding/interaction research compiled
in the HIV-1, Human Protein Interaction Database, recent
experimental studies based on genome-wide siRNA
screens have brought additional light to host-pathogen
interactions that facilitate HIV-1 replication [6,35,36].
Three studies produced smaller lists of host proteins than
the list in the HIV-1, Human Protein Interaction Data-
base. The lower matrix in Figure 7 shows the five-way
comparison of HIV-1 targeted protein lists: HHE, HHP,
and the three screens. The table indicated the extent of dis-
crepancy between lists, as well as the statistical signifi-
cance of the matches between them. Our predictions
matched HHE with the lowest p-value, and the genome-
wide study lists generally matched each other better than
the interaction studies. The list of 280 genes presented as
host cellular factors required for HIV-1 replication by
Brass et al. had 13 genes in common with the list of 295
genes deemed necessary by Konig et al. for regulation of
early stage HIV-1 replication, and shared 10 genes with
the 311 genes given in the Zhou study. When these pro-
teins were projected into HPRD, the matches led to p-val-
HIV-1 TAT T cell receptor signaling pathway Figure 6
HIV-1 TAT T cell receptor signaling pathway. The KEGG T cell receptor signaling pathway is colored for TAT HHP 
(blue) and HHE (red), and their overlap (purple). Green boxes have proteins not involved in infection, while white boxes do 
not have human proteins.BMC Medical Genomics 2009, 2:27 http://www.biomedcentral.com/1755-8794/2/27
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ues of 7.35 E-4 and 4.46 E-5. Although the match was
significant, there was still a discrepancy between the
results. This mismatch may be attributed to the differences
in the analysis and experimental methodologies used.
Our predictions matched 56 of the 129 HPRD proteins
presented by Konig et al. with a p-value of 0.15, 44 of the
91 HPRD proteins in the list by Brass et al. with a p-value
of 0.03, and 54 of the 139 HPRD proteins given by Zhou
et al. with a p-value of 0.52. These results indicated the
challenges faced by experimental studies trying to uncover
the grammar of HIV-1, host interactions.
Although our study produced host protein sets statistically
enriched with proteins known to be targeted by HIV-1,
mismatches between our predictions and experimental
data cannot be ignored. It is possible that host-virus inter-
actions employ a grammar that is much more complex
than the short linear motif/counter domain interactions
assumed in this study. The molecular vocabulary of PPIs
is simply not well understood even for proteins belonging
to the same species. However, one common mode of
interaction is the binding of a linear binding motif on one
protein to a domain on another protein [37]. A central
hypothesis in the discovery of the linear binding motifs
mediating protein interactions has been that proteins
with a common interacting partner, such as protein
kinases, share a common feature in the form of a motif
[38]. Some of the linear binding motifs in the ELM
resource have been shown to bind directly to sites at
opposing counter domains listed in databases such as
PROSITE and Pfam [39]. However, for approximately
30% of the PPI interactions listed in HPRD database,
interacting proteins possess none of the already annotated
domains. Thus, a model based on known motif/domain
interactions would not be able to capture all of the known
interactions in the host, let alone those between virus and
host.
Another important cause of the discrepancy between our
predictions and experimental data might have been the
poor annotation of known motifs and counter domains
used in this study [40]. Recent studies of domain-motif
interactions indicated that the annotation signatures are
more specific than those presented in ELM and PROSITE.
This was found to be true for the HIV-1 interacting PDZ
domain [12], SH3 domain [13] and others [14]. Emerging
motif finding tools such as DILIMOT [41], SLIMFinder
[42], and D-STAR [43] will help researchers improve the
specificity of the motifs that mediate host-virus interac-
tions. Still, the list of host proteins we have provided [see
Additional file 5] comprises a candidate set for genome-
wide studies of the regulation of HIV-1 replication and
infection.
Comparison of combined HHP and HHE Figure 7
Comparison of combined HHP and HHE. HHP and HHE 
are combined across all HIV-1 proteins. HHP performance is 
compared when restricting it to genes in HPRD, KEGG, and 
KEGG pathways enriched in HHP (p-value < .01, see Meth-
ods). The lower table compares HHE, HHP, and predictions 
from three siRNA screens. The darkened diagonal holds the 
sizes of all sets. The overlap between sets is below the diago-
nal, while p-values for these overlaps are above (see Meth-
ods).
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Comparison of HHP and HHE for HPRD proteins Figure 8
Comparison of HHP and HHE for HPRD proteins. 
HIV-1 proteins ENV, NEF, and TAT had significant overlap 
between HHP and HHE. This was true when we looked at all 
conserved ELMs or ELM pairs occurring below some fraction 
(Frac) in the human proteome. P-values were calculated as 
described in Methods.
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We focused on HIV-1 infection in this study because we
desired to assess the effectiveness of our computational
approach by comparing our predictions with large-scale
experimental data. Our results provided a rationale for
applying our method to predict virus-human interactions
for sequenced viruses. A systems approach to predicting
host-pathogen interactions will at least be partially based
on the sequence motifs of interacting genome/proteomes.
The present study illustrated the importance of ELMs in
the molecular cross talk between host and virus and
opened the door for more extensive experimental and
computational studies of host-virus interactions.
Conclusion
In this study, we described a bioinformatics model to
investigate the crosstalk between the HIV-1 and human
proteins. Our method used multiple sequence alignments
of HIV-1 proteins, and three datasets related to the host:
decoded sequences of the host proteins, a priori knowl-
edge of experimentally observed protein-protein interac-
tions within the host proteome, and interactions between
short linear peptide motifs and protein domains. The out-
put of the model was a list of host proteins that may inter-
act with specific HIV-1 proteins using specific sites. This
list can be used to draft a connectivity map between virus
and host, and to determine a set of protein interaction
pathways that are significantly enhanced by host proteins
predicted to be targeted by HIV-1.
The model was based on the assumption that virus pro-
teins interact with host proteins though a set of conserved
linear sequence motifs present in the host proteome. The
conserved spatial organization of these motifs on the rap-
idly evolving HIV-1 proteome supported the assertion
that short linear motifs play critical roles in interactions
with the host network. The model's predictions led to host
protein sets that are crowded by known HIV-1 targeted
proteins. This statistical enrichment was particularly high
along cellular pathways modulated by HIV-1. The model's
predictions were also consistent with experimental data
showing phosphorylation events as key targets of HIV-1
when redirecting cell protein networks toward the goal of
virus replication.
The methodology applied here for HIV-1, host protein
interactions is applicable to any viruses with multiple
sequence alignments and hosts with known interactomes.
Therefore, our approach has potential use in the identifi-
cation of host proteins targeted by emerging and/or
understudied viruses. The resulting list will be useful for
selecting optimal drug therapies and discovering new
antivirus drugs. The systems approach presented here for
predicting host-virus protein interactions will benefit
from ongoing research on the more specific annotations
of short linear motifs and domains involved in protein-
protein interactions.
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the two protein sets. P-values are calculated as the probability of matching 
Match genes or more when comparing DHHE and H1 drawn from the 
5954 proteins in the study (see Methods).
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Comparison of HHP and HHE for KEGG proteins for each HIV-1 pro-
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